<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01935206</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2012-174</org_study_id>
    <nct_id>NCT01935206</nct_id>
  </id_info>
  <brief_title>Effect of High Dose Naloxone on Secondary Hyperalgesia</brief_title>
  <official_title>Effect of a High-dose Naloxone Infusion on Secondary Hyperalgesia After a First-degree Burn</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent studies have focused on the role of endogenous opioids on central sensitization.
      Central sensitization is known to be impaired or altered in chronic pain conditions, as
      fibromyalgia or chronic tension headache.

      Animal studies have shown reinstatement of mechanical hypersensitivity following naloxone
      administration after resolution of an injury. This suggests latent sensitization.

      In the present study, investigators hypothesize that naloxone (2 mg/kg) can reinstate
      secondary hyperalgesia 168 hours after a first-degree burn-injury. Investigators aim
      therefore to show that latent sensitization is present in humans and is modulated by
      endogenous opioids.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Secondary hyperalgesia area (cm2) surrounding a first-degree burn injury before and after infusion of naloxone/placebo</measure>
    <time_frame>1h, 2h, 3h, 168h, 168h15min, 168h30min post-burn</time_frame>
    <description>Areas of secondary hyperalgesia surrounding a first degree burn-injury will be assessed before and after infusion of naloxone/placebo.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in allodynic area (cm2) surrounding a first-degree burn injury before and after infusion of naloxone/placebo</measure>
    <time_frame>1h, 2h, 3h, 168h, 168h15min, 168h30min post-burn</time_frame>
    <description>Areas of allodynia surrounding a first degree burn-injury will be assessed before and after infusion of naloxone/placebo.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Mechanical Pain Thresholds at primary hyperalgesia site before and after naloxone/placebo infusion</measure>
    <time_frame>0h, 168h, 168h30min</time_frame>
    <description>Mechanical Pain Thresholds will be assessed with pinprick stimulators at baseline and after infusion of naloxone/placebo at the primary hyperalgesia site (following a first degree burn) and in the contralateral leg.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Hyperalgesia</condition>
  <condition>Pain</condition>
  <condition>Naloxone</condition>
  <condition>Opioid Antagonist</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The effect of naloxone (2 mg/kg) on secondary hyperalgesia 168 hours after a first-degree burn-injury is compared to the placebo effect.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Naloxone (2 mg/kg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The effect of naloxone (2 mg/kg) on secondary hyperalgesia 168 hours after a first-degree burn-injury is compared to the placebo effect.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naloxone (2 mg/kg)</intervention_name>
    <arm_group_label>Naloxone (2 mg/kg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy man

          -  written informed consent

          -  ASA 1-2

          -  BMI 18 &lt; BMI &lt; 30

          -  normal ultrasound examination of the heart

          -  normal ECG

          -  urin sample without traces of opioids

        Exclusion Criteria:

          -  volunteers, who do not understand the Danish language

          -  participation in another experimental trial in the previous 60 days

          -  nerve damage or skin lesions in the assessment areas

          -  neurological or psychiatric condition

          -  use of psycho-active drugs

          -  abuse of alcohol or drugs

          -  chronic pain

          -  regular use of pain-killers (&gt; 1 a week)

          -  allergy against morphine or other opioids (including naloxone)

          -  use of prescription drugs 1 week prior to the trial

          -  use of over-the-counter medication 48 hours prior to the trial

          -  urin sample with traces of opioids

          -  volunteer is not suitable for the trial according to the investigator's consideration
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joergen B Dahl, M.D., DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Dept Anaesthesiology, HOC, 4231, Rigshospitalet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mads U. Werner, M.D., Ph.D., DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multidisciplinary Pain Center, 7612, Rigshospitalet, Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept Anaesthesiology HOC, 4231, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multidisciplinary Pain Center</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2013</study_first_submitted>
  <study_first_submitted_qc>August 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>February 24, 2014</last_update_submitted>
  <last_update_submitted_qc>February 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Manuel Pereira</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>secondary hyperalgesia</keyword>
  <keyword>allodynia</keyword>
  <keyword>mechanical pain threshold</keyword>
  <keyword>naloxone</keyword>
  <keyword>endogenous opioids</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

